Literature DB >> 11417996

Heterogeneity of so-called neuroendocrine lung tumors.

R Yesner1.   

Abstract

The diagnosis of neuroendocrine (NE) lung tumor is dependent on a number of observations: organoid structure, dense core granules, and various molecular components, including chromogranin A, neurosecretory enolase, synaptophysin, neural cell adhesion molecules, and others. None of these is specific for lung tumors. The Kulchitsky cell, which has these characteristics, forms a carcinoid, which exemplifies the NE tumor. It is euploid, has few mitoses, no necrosis and a 5- to 10-year survival of over 90%. When carcinoids show malignant characteristics, i.e., increased mitoses and necrosis, they have been labeled atypical and have a survival of 50%. Because all other non-small cell lung tumors, especially large cell tumors, may show one or more of these things because of the inherent heterogeneity of lung tumors, the term NE has been applied to them without real evidence that this affects survival with or without chemotherapy. This is expensive and without clinical significance. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11417996     DOI: 10.1006/exmp.2001.2373

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  10 in total

Review 1.  Mechanisms of storage and exocytosis in neuroendocrine tumors.

Authors:  Manfred Gratzl; Martin Breckner; Christian Prinz
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

2.  Establishment and characterization of a human large cell lung cancer cell line with neuroendocrine differentiation.

Authors:  Sedigheh Sharifzadeh; S Mohammad Owji; Abdul Mohammad Pezeshki; Zahra Malek-Hoseini; Perikala Vijayananda Kumar; Sied Mohammad Ali Ghayumi; Abbas Ghaderi
Journal:  Pathol Oncol Res       Date:  2004-12-27       Impact factor: 3.201

3.  Cell of origin of lung cancer.

Authors:  Kate D Sutherland; Anton Berns
Journal:  Mol Oncol       Date:  2010-06-08       Impact factor: 6.603

4.  Array comparative genomic hybridization-based characterization of genetic alterations in pulmonary neuroendocrine tumors.

Authors:  Johannes Voortman; Jih-Hsiang Lee; Jonathan Keith Killian; Miia Suuriniemi; Yonghong Wang; Marco Lucchi; William I Smith; Paul Meltzer; Yisong Wang; Giuseppe Giaccone
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-06       Impact factor: 11.205

Review 5.  [Neuroendocrine tumors of the lung].

Authors:  K-M Müller
Journal:  Pathologe       Date:  2003-05-29       Impact factor: 1.011

Review 6.  Cellular and molecular biology of small cell lung cancer: an overview.

Authors:  Niki Karachaliou; Sara Pilotto; Chiara Lazzari; Emilio Bria; Filippo de Marinis; Rafael Rosell
Journal:  Transl Lung Cancer Res       Date:  2016-02

Review 7.  Advanced small cell lung cancer (SCLC): new challenges and new expectations.

Authors:  Nikolaos Tsoukalas; Eleni Aravantinou-Fatorou; Panagiotis Baxevanos; Maria Tolia; Konstantinos Tsapakidis; Michail Galanopoulos; Michail Liontos; George Kyrgias
Journal:  Ann Transl Med       Date:  2018-04

Review 8.  Targeting the Complement Pathway as a Therapeutic Strategy in Lung Cancer.

Authors:  Emily K Kleczko; Jeff W Kwak; Erin L Schenk; Raphael A Nemenoff
Journal:  Front Immunol       Date:  2019-05-10       Impact factor: 7.561

9.  Cell of origin of lung cancer.

Authors:  Jennifer M Hanna; Mark W Onaitis
Journal:  J Carcinog       Date:  2013-03-16

10.  Upregulation of SQSTM1/p62 contributes to nickel-induced malignant transformation of human bronchial epithelial cells.

Authors:  Haishan Huang; Junlan Zhu; Yang Li; Liping Zhang; Jiayan Gu; Qipeng Xie; Honglei Jin; Xun Che; Jingxia Li; Chao Huang; Lung-Chi Chen; Jianxin Lyu; Jimin Gao; Chuanshu Huang
Journal:  Autophagy       Date:  2016-07-28       Impact factor: 16.016

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.